178 related articles for article (PubMed ID: 28303450)
1. DRα1-MOG-35-55 treatment reduces lesion volumes and improves neurological deficits after traumatic brain injury.
Yang L; Liu Z; Ren H; Zhang L; Gao S; Ren L; Chai Z; Meza-Romero R; Benedek G; Vandenbark AA; Offner H; Li M
Metab Brain Dis; 2017 Oct; 32(5):1395-1402. PubMed ID: 28303450
[TBL] [Abstract][Full Text] [Related]
2. A novel HLA-DRα1-MOG-35-55 construct treats experimental stroke.
Benedek G; Zhu W; Libal N; Casper A; Yu X; Meza-Romero R; Vandenbark AA; Alkayed NJ; Offner H
Metab Brain Dis; 2014 Mar; 29(1):37-45. PubMed ID: 24122483
[TBL] [Abstract][Full Text] [Related]
3. DRα1-MOG-35-55 Reduces Permanent Ischemic Brain Injury.
Wang J; Ye Q; Xu J; Benedek G; Zhang H; Yang Y; Liu H; Meza-Romero R; Vandenbark AA; Offner H; Gao Y
Transl Stroke Res; 2017 Jun; 8(3):284-293. PubMed ID: 27988839
[TBL] [Abstract][Full Text] [Related]
4. Increased CD74 binding and EAE treatment efficacy of a modified DRα1 molecular construct.
Meza-Romero R; Benedek G; Gerstner G; Kent G; Nguyen H; Offner H; Vandenbark AA
Metab Brain Dis; 2019 Feb; 34(1):153-164. PubMed ID: 30353480
[TBL] [Abstract][Full Text] [Related]
5. HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection.
Benedek G; Meza-Romero R; Jordan K; Keenlyside L; Offner H; Vandenbark AA
J Neuroinflammation; 2015 Jun; 12():123. PubMed ID: 26104759
[TBL] [Abstract][Full Text] [Related]
6. HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis.
Meza-Romero R; Benedek G; Yu X; Mooney JL; Dahan R; Duvshani N; Bucala R; Offner H; Reiter Y; Burrows GG; Vandenbark AA
J Immunol; 2014 May; 192(9):4164-73. PubMed ID: 24683185
[TBL] [Abstract][Full Text] [Related]
7. A novel antagonist of p75NTR reduces peripheral expansion and CNS trafficking of pro-inflammatory monocytes and spares function after traumatic brain injury.
Lee S; Mattingly A; Lin A; Sacramento J; Mannent L; Castel MN; Canolle B; Delbary-Gossart S; Ferzaz B; Morganti JM; Rosi S; Ferguson AR; Manley GT; Bresnahan JC; Beattie MS
J Neuroinflammation; 2016 Apr; 13(1):88. PubMed ID: 27102880
[TBL] [Abstract][Full Text] [Related]
8. Salsalate treatment following traumatic brain injury reduces inflammation and promotes a neuroprotective and neurogenic transcriptional response with concomitant functional recovery.
Lagraoui M; Sukumar G; Latoche JR; Maynard SK; Dalgard CL; Schaefer BC
Brain Behav Immun; 2017 Mar; 61():96-109. PubMed ID: 27939247
[TBL] [Abstract][Full Text] [Related]
9. Novel humanized recombinant T cell receptor ligands protect the female brain after experimental stroke.
Pan J; Palmateer J; Schallert T; Hart M; Pandya A; Vandenbark AA; Offner H; Hurn PD
Transl Stroke Res; 2014 Oct; 5(5):577-85. PubMed ID: 24838614
[TBL] [Abstract][Full Text] [Related]
10. Traumatic brain injury causes selective, CD74-dependent peripheral lymphocyte activation that exacerbates neurodegeneration.
Tobin RP; Mukherjee S; Kain JM; Rogers SK; Henderson SK; Motal HL; Newell Rogers MK; Shapiro LA
Acta Neuropathol Commun; 2014 Oct; 2():143. PubMed ID: 25329434
[TBL] [Abstract][Full Text] [Related]
11. Laquinimod attenuates inflammation by modulating macrophage functions in traumatic brain injury mouse model.
Katsumoto A; Miranda AS; Butovsky O; Teixeira AL; Ransohoff RM; Lamb BT
J Neuroinflammation; 2018 Jan; 15(1):26. PubMed ID: 29382353
[TBL] [Abstract][Full Text] [Related]
12. Cordycepin confers long-term neuroprotection via inhibiting neutrophil infiltration and neuroinflammation after traumatic brain injury.
Wei P; Wang K; Luo C; Huang Y; Misilimu D; Wen H; Jin P; Li C; Gong Y; Gao Y
J Neuroinflammation; 2021 Jun; 18(1):137. PubMed ID: 34130727
[TBL] [Abstract][Full Text] [Related]
13. Microglial-derived microparticles mediate neuroinflammation after traumatic brain injury.
Kumar A; Stoica BA; Loane DJ; Yang M; Abulwerdi G; Khan N; Kumar A; Thom SR; Faden AI
J Neuroinflammation; 2017 Mar; 14(1):47. PubMed ID: 28292310
[TBL] [Abstract][Full Text] [Related]
14. Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental Traumatic Brain Injury Reduces Neurodegeneration and Neurological Deficits.
Henry RJ; Ritzel RM; Barrett JP; Doran SJ; Jiao Y; Leach JB; Szeto GL; Wu J; Stoica BA; Faden AI; Loane DJ
J Neurosci; 2020 Apr; 40(14):2960-2974. PubMed ID: 32094203
[TBL] [Abstract][Full Text] [Related]
15. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury.
Xu X; Yin D; Ren H; Gao W; Li F; Sun D; Wu Y; Zhou S; Lyu L; Yang M; Xiong J; Han L; Jiang R; Zhang J
Neurobiol Dis; 2018 Sep; 117():15-27. PubMed ID: 29859317
[TBL] [Abstract][Full Text] [Related]
16. Disruption of Midkine gene reduces traumatic brain injury through the modulation of neuroinflammation.
Takada S; Sakakima H; Matsuyama T; Otsuka S; Nakanishi K; Norimatsu K; Itashiki Y; Tani A; Kikuchi K
J Neuroinflammation; 2020 Jan; 17(1):40. PubMed ID: 31996236
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of acute administration of inhaled argon on traumatic brain injury in mice.
Moro F; Fossi F; Magliocca A; Pascente R; Sammali E; Baldini F; Tolomeo D; Micotti E; Citerio G; Stocchetti N; Fumagalli F; Magnoni S; Latini R; Ristagno G; Zanier ER
Br J Anaesth; 2021 Jan; 126(1):256-264. PubMed ID: 32977957
[TBL] [Abstract][Full Text] [Related]
18. Withaferin A alleviates traumatic brain injury induced secondary brain injury via suppressing apoptosis in endothelia cells and modulating activation in the microglia.
Zhou Z; Xiang W; Jiang Y; Tian N; Wei Z; Wen X; Wang W; Liao W; Xia X; Li Q; Liao R
Eur J Pharmacol; 2020 May; 874():172988. PubMed ID: 32032599
[TBL] [Abstract][Full Text] [Related]
19. IL-13 Ameliorates Neuroinflammation and Promotes Functional Recovery after Traumatic Brain Injury.
Miao W; Zhao Y; Huang Y; Chen D; Luo C; Su W; Gao Y
J Immunol; 2020 Mar; 204(6):1486-1498. PubMed ID: 32034062
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of metformin on traumatic brain injury in rats associated with NF-κB and MAPK signaling pathway.
Tao L; Li D; Liu H; Jiang F; Xu Y; Cao Y; Gao R; Chen G
Brain Res Bull; 2018 Jun; 140():154-161. PubMed ID: 29698747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
